---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-088600"
form_type: "8-K"
ticker: "APGE"
cik: "0001974640"
company_name: "Apogee Therapeutics, Inc."
filed_at: "2025-06-23T23:59:59+00:00"
generated_at: "2026-05-19T00:16:06.577115+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Apogee Therapeutics shareholders elect directors and ratify auditor at 2025 annual meeting

## Summary
- Elected Class II directors: Bollinger (35.1M for, 4.3M withheld), Kiselak (39.2M for), Shah (25.8M for, 13.6M withheld).
- Ratified Ernst & Young as independent auditor for FY2025 (41.2M for, 3K against).
- Advisory vote on say-on-pay frequency: 39.4M voted for one year; company will hold annual say-on-pay votes going forward.
- Broker non-votes of 1,795,017 on director elections and frequency vote.

## SEC filing metadata
- accession: 0000950170-25-088600
- form_type: 8-K
- ticker: APGE
- cik: 0001974640
- company_name: Apogee Therapeutics, Inc.
- filed_at: 2025-06-23T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1974640/000095017025088600/0000950170-25-088600-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1974640/000095017025088600/apge-20250617.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-088600
- JSON: https://secwatch.observer/filing/0000950170-25-088600.json
- Plain text: https://secwatch.observer/filing/0000950170-25-088600.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.